Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis

BACKGROUND: The preferred regimen for HIV post-exposure prophylaxis (PEP) is based mainly on safety and tolerability because it is given to immunocompetent people without HIV infection for a limited time (28 days). The frequency of adverse events (AEs) may be > 60%. Although AEs are generally not...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Infect Dis
Autori principali: Valin, Nadia, Fonquernie, Laurent, Daguenel, Anne, Campa, Pauline, Anthony, Theresita, Guiguet, Marguerite, Girard, Pierre Marie, Meyohas, Marie Caroline
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2016
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5127047/
https://ncbi.nlm.nih.gov/pubmed/27894270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-016-2056-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi